Beurswaarde geschiedenis voor Pharming Group N.V.
| Datum | Beurswaarde |
|---|---|
| 1 jun. 2023 | 742.117.894,00 € |
| 31 mei 2023 | 731.837.473,00 € |
| 30 mei 2023 | 739.547.789,00 € |
| 29 mei 2023 | 762.678.737,00 € |
| 26 mei 2023 | 757.538.526,00 € |
| 25 mei 2023 | 745.973.052,00 € |
| 24 mei 2023 | 751.113.263,00 € |
| 23 mei 2023 | 764.606.316,00 € |
| 22 mei 2023 | 753.683.368,00 € |
| 19 mei 2023 | 734.407.579,00 € |
| 18 mei 2023 | 720.272.000,00 € |
| 17 mei 2023 | 702.923.789,00 € |
| 16 mei 2023 | 711.276.631,00 € |
| 15 mei 2023 | 706.778.947,00 € |
| 12 mei 2023 | 697.141.052,00 € |
Beurswaarde in Healthcare bedrijven
| Bedrijfsnaam | Beurswaarde | |
|---|---|---|
 |
Abbott Laboratories ABT |
177.757.140.711,00 € |
 |
AbbVie Inc. ABBV |
237.101.891.072,00 € |
 |
American Shared Hospital Services AMS |
18.413.520,00 € |
 |
Amplifon S.p.A. AMP.MI |
7.334.197.707,00 € |
 |
Asensus Surgical, Inc. ASXC |
121.522.800,00 € |
 |
AstraZeneca PLC AZN |
226.339.880.000,00 € |
 |
Atossa Therapeutics, Inc. ATOS |
117.418.435,00 € |
 |
Baxter International Inc. BAX |
20.699.950.000,00 € |
 |
Bayer Aktiengesellschaft BAYN.DE |
50.987.599.964,00 € |
 |
BeiGene, Ltd. BGNE |
23.573.987.641,00 € |
 |
BioCryst Pharmaceuticals, Inc. BCRX |
1.566.509.790,00 € |
 |
Biogen Inc. BIIB |
44.047.776.000,00 € |
 |
BIOLASE, Inc. BIOL |
2.781.948,80 € |
 |
Bionano Genomics, Inc. BNGO |
215.327.880,00 € |
 |
BioNTech SE BNTX |
25.486.043.514,00 € |
 |
Bristol-Myers Squibb Company BMY |
135.679.360.000,00 € |
 |
Cegedim SA CGM.PA |
277.716.085,00 € |
 |
Clover Health Investments, Corp. CLOV |
417.039.213,00 € |
 |
CRISPR Therapeutics AG CRSP |
4.981.433.368,00 € |
 |
EssilorLuxottica Société anonyme EL.PA |
73.645.502.997,00 € |
 |
Eurofins Scientific SE ERF.PA |
11.750.200.192,00 € |
 |
Exicure, Inc. XCUR |
3.880.355,64 € |
 |
Fagron NV FAGR.BR |
1.219.676.042,00 € |
 |
Galapagos NV GLPG.AS |
2.524.258.531,00 € |
 |
Galapagos NV GLPG |
2.706.599.245,00 € |
 |
Genfit S.A. GNFT |
205.650.095,00 € |
 |
Genmab A/S GMAB |
26.090.837.512,00 € |
 |
GoodRx Holdings, Inc. GDRX |
2.225.054.455,00 € |
 |
Healthcare Triangle, Inc. HCTI |
121.392.639,00 € |
 |
iBio, Inc. IBIO |
9.327.680,00 € |
 |
Inovio Pharmaceuticals, Inc. INO |
149.893.874,00 € |
 |
Intrasense SA ALINS.PA |
12.226.045,00 € |
 |
Jaguar Health, Inc. JAGX |
3.155.183,56 € |
 |
Johnson & Johnson JNJ |
408.106.019.430,00 € |
 |
Koninklijke Philips N.V. PHIA.AS |
15.657.539.596,00 € |
 |
Media Lab S.p.A. MLLAB.PA |
3.578.700,00 € |
 |
Medtronic plc MDT |
110.479.784.000,00 € |
 |
Merck & Co., Inc. MRK |
283.037.760.000,00 € |
 |
Moderna, Inc. MRNA |
49.498.710.000,00 € |
 |
Nektar Therapeutics NKTR |
115.383.737,00 € |
 |
NextGen Healthcare, Inc. NXGN |
1.040.007.554,00 € |
 |
Novacyt S.A. ALNOV.PA |
33.123.710,00 € |
 |
Novan, Inc. NOVN |
29.902.803,00 € |
 |
Novavax, Inc. NVAX |
686.765.418,00 € |
 |
Novo Nordisk A/S NVO |
357.596.416.000,00 € |
 |
Nutex Health, Inc. NUTX |
282.237.044,00 € |
 |
Ocugen, Inc. OCGN |
102.726.012,00 € |
 |
OpGen, Inc. OPGN |
3.341.406,37 € |
 |
Orchard Therapeutics plc ORTX |
69.192.865,00 € |
 |
Organon & Co. OGN |
4.989.899.080,00 € |
 |
Pear Therapeutics, Inc. PEAR |
4.050.252,52 € |
 |
Pfizer Inc. PFE |
214.768.080.000,00 € |
 |
Privia Health Group, Inc. PRVA |
2.871.199.934,00 € |
 |
Roche Holding AG RO.SW |
262.989.994.900,00 € |
 |
Sanofi SAN.PA |
117.696.570.969,00 € |
 |
Signify Health, Inc. SGFY |
8.933.386.237,00 € |
 |
Teladoc Health, Inc. TDOC |
3.844.975.507,00 € |
 |
Thermo Fisher Scientific Inc. TMO |
200.480.680.000,00 € |
 |
Tilray Brands, Inc. TLRY |
1.091.910.379,00 € |
 |
Tonix Pharmaceuticals Holding Corp. TNXP |
18.955.185,00 € |
 |
Vaxart, Inc. VXRT |
162.255.835,00 € |
 |
Vertex Pharmaceuticals Incorporated VRTX |
82.715.490.000,00 € |
 |
Zomedica Corp. ZOM |
195.009.983,00 € |
